Advanced search
Publication Cover
Leukemia & Lymphoma Volume 35, 1999 - Issue 3-4
Submit an article Journal homepage
13
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of Mitoguazone in Patients with Refractory Chronic Lymphocytic Leukemia: A Phase II Study (P-H482) of the Eastern Cooperative Oncology Group

Peter H. Wiernik Alberi Einstein Cancer Center, Bronx, New York
,
Leo I. Gordon Northwestern University Medical Center, Chicago, IL
,
Martin M. Oken Virginia Piper Cancer Institute, Minneapolis, MN
,
Jules E. Harris Rush Presbyterian St. Luke's Medical Center, Chicago, IL
&
Michael J. Oconnell Mayo Clinic, Rochester, MN, USA
Pages 375-377 | Received 30 Sep 1998, Published online: 01 Jul 2009

References

  • O'Brien S., Kantarjian H., Beran M., Smith T., Koller C., Estey E., Robertson L. E., Lemer S., Keating M. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivari-ate analysis-derived prognostic model for response to treatment. Blood 1993; 82: 1695–1700
  • Dreger P., von Neuhoff N., Kuse R., Sonnen R., Glass B., Uharek L., Schoch R., Loffler H., Schmitz N. Early stern cell transplantation for chronic lymphocytic leukemia: a chance for cure?. Br. J. Haematol. 1998; 77: 2291–2297
  • Rai K. R., Sawitsky A., Cronkite E. P., Chanana A. D., Levy R. N., Pastemak B. S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
  • Oken M. M., Creech R. H., Tormey D. C., Horton J., Davis T. E., McFadden E. T., et al. Toxicity and response criteria of the Eastern Cooperatvive Oncology Group Am. J. Clin. Oncol. 1982; 5: 649–655
  • Levine A. M., Tulpule A., Tessman D., Kaplan L., Giles E, Luskey B. D., Scadden D. T., Northfelt D. W., Silverberg I., Wernz J., Espina B., Von Hoff D. Mitogua-zone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial. J. Clin. Oncol. 1997; 15: 1094–1103
  • Mirza M. R., Brincker H. MIME combination chemotherapy in recurrent or refractory lymphoproliferative malignancies. A phase II study. Acta Oncol. 1991; 30: 17–21
  • Wiemik P. H., Moore D. F., Bennett J. M., Vogl S. E., Harris J. E., Luger S., Oken M. M., Glick J. H. Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vinc-ristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: An Eastern Cooperative Oncology Group study (PE481). Leukemia & Lymphoma 1998; 30: 601–607
  • Wiemik P. H., Phillips V., Camacho EJ., Oken M. M., O'Connell M. J. Methylguazone, vindesine and cispl-atin for the treatment of patients with relapsed or refractory malignant lymphoma: An Eastern Cooperative Oncology Group study (PA482). Leukemia &. Lymphoma 1998; 30: 619–624
  • Rizzo J., Levine A. M., Weiss G. R., Pearce T., Kraynak M., m Mueck R., Smith S., Von Hoff D. D., Kuhn J. G. Pharmacokinetic profile of mitoguazone (MGBG) in patients with AIDS related non-Hodgkin's lymphoma. Invest. New Drugs 1996; 14: 227–234

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.